The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm) lead, which ...

GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded ...

Oslo, Norway - Delaying defibrillation until preliminary CPR is performed can improve survival in patients who have had longer duration ventricular fibrillation (VF), investigators say. Their ...

The study, published in the New England Journal of Medicine on Nov. 24, studied patient outcomes for three methods of defibrillation: standard defibrillation; double sequential external defibrillation ...

Some patients are having their defibrillation leads taken out early due to shock coil calcification, according to an FDA alert. Boston Scientific has informed healthcare providers that device leads ...

In a paper published this week in Chaos, by AIP Publishing, researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta used an ...

A team of researchers from Sergio Arboleda University in Bogotá, Colombia, and the Georgia Institute of Technology in Atlanta utilized an electrophysiological computer model of the heart’s electrical ...

An international team of scientists is on the cutting edge of a new treatment for cardiac arrhythmia that uses light beams instead of electricity to restore the heart’s healthy beat. The new method of ...

Registry data suggest that one third of the patients who would benefit most are not receiving timely defibrillation. In the U.S., in-hospital cardiac arrest occurs about twice as often as ...

defibrillation-cardiovascular-CA0516 Deferred defibrillation was not associated with improved survival. Delaying a second attempt at defibrillation to allow time for chest compressions, as revisions ...